EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe

The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) today kicked off a new initiative aimed at strengthening post-marketing monitoring of the safety, effectiveness and impact of COVID-19 vaccines in the EU/EEA.

Other news